Sentara Comprehensive Weight Loss Solutions
2790 Godwin Boulevard · Suffolk, VA 23434
4.8(22 Google reviews · 22 in past year)
TelehealthAccepts insurance
Listing updated Oct 2, 2026
Bon Secours Surgical Weight Loss - Harbour View
Bon Secours Surgical Weight Loss - Harbour View · 5838 Harbour View Boulevard · Suffolk, VA 23435
4.6· 15 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
About this practice
Bon Secours Surgical Weight Loss - Harbour View is a surgical weight-loss practice location in Suffolk, Virginia. On Google it has a 4.6-star rating across 15 reviews dating back to 2018, with one posted in the past year. Reviewers most often mention the staff, with single mentions of results and the providers' knowledge.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 4.6
Google rating · 15 reviews
1
reviews in the past year (avg ★ 5.0)
1
reviews mention weight loss
Counts computed by RetaMaps from public Google reviews; most recent review 2026-07-03. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.6 across 15 Google reviews. Of the 12 reviews we analyzed, 11 (92%) are positive (4–5★) and 1 (8%) are negative (1–2★).
What patients like
- Friendly, helpful staff3 reviews
Common complaints
Very few complaints — only 1 negative review, with no recurring theme.
5★
11
4★
0
3★
0
2★
0
1★
1
Most recent Google reviews
April H.★★★★★2025-08-12Natasha has been amazing and so helpful. Always messages me back super quick on MyChart. She's made this journey so much easier for me
Tip M.★★★★★2024-03-28Dr. Kuduv is the worst . He linger his patients around
Mia M.★★★★★2023-12-01Very professional and considerate staff
Scotland T.★★★★★2020-08-31The best place to start your journey well rounded programming set up before and after the weight loss procedure
Chloe S.★★★★★2019-09-25Best doctors and staff I've ever come into contact with. The facility is gorgeous and well kept, and the location is great. The doctors are life changers, the nutritionists are so helpful and kind, and the nurses are wonderful. I cant say enough great things about this place. Dr. Adam's is the best doctor! If you have been thinking about surgery, then do its stick with the changes and these doctors will set u up for success!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Suffolk
Accepts insurance3 reviews mention GLP-1
Listing updated Oct 2, 2026
Virginia Plastic Surgery
1037 Champions Way · Suffolk, VA 23435
5.0(305 Google reviews · 41 in past year)
Accepts insurance
Listing updated Oct 2, 2026
Accepts insurance
Listing updated Oct 2, 2026
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs